What the media is reporting about MassBio
News from the biotechnology industry
Showing news: 381–390 of 411
March 24, 2009 —
March 24, 2009 (Cambridge, MA)- The Massachusetts Biotechnology Council (MBC) today announced the launch of the first-ever Federal Legislative Scorecard, designed to monitor issues important to the life sciences industry and better communicate with…
March 18, 2009 —
To view or download the Spring 2009 MBC Newsletter click here or click on the newsletter icon at the top of massbio.org.
March 18, 2009 —
The IRS has just released information relative to changes in the net operating loss carryback for small businesses. Small businesses with deductions exceeding their income in 2008 can use a new net operating loss tax provision in the American Recovery…
March 17, 2009 —
MBC member companies have the opportunity to access qualified summer interns through the new Internship Challenge run by the Massachusetts Life Science Center.
Undergraduates concentrating in the study of science, technology, engineering,…
March 12, 2009 —
February 26, 2009 —
The last day of February has been designated as Rare Disease Day in Massachusetts to call attention to the public health issues associated with rare diseases, which affect nearly 30 million Americans and countless others around the world.
January 28, 2009 —
Ensuring patient access to innovative new drugs and therapies that solve unmet medical needs should be the focus of President Barack Obama and the members of the 111th Congress as they consider health care reform, according to a Massachusetts…
January 25, 2009 —
January 14, 2009 —
Biotechnology companies can now apply for the new state tax incentives and grant programs outlined in the Massachusetts Life Science Initiative. Deadline to apply for first round of Accelerator funding is March 6, 2009 and the deadline to apply for tax…
January 9, 2009 —
Proposed pharmaceutical and medical device sales & marketing regulations will jeopardize the momentum of the growing life sciences industry in Massachusetts, MBC President & CEO Robert Coughlin testified at a hearing today.